Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease.
暂无分享,去创建一个
N. Hayashi | T. Kanto | M. Tsujii | S. Egawa | Takahiro Inoue | H. Iijima | Y. Hayashi | Akira Mukai | T. Nishida | S. Shinzaki | J. Kondo | T. Akasaka | Sachiko Nakajima | J. Ying | S. Nakajima
[1] Z. Tulassay,et al. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients , 2009, Inflammatory bowel diseases.
[2] T. Chiba,et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease , 2009, Osteoporosis International.
[3] W. Leslie,et al. Vitamin D Status and Bone Density in Recently Diagnosed Inflammatory Bowel Disease: The Manitoba IBD Cohort Study , 2008, The American Journal of Gastroenterology.
[4] R. D'Agostino,et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. , 2007, American journal of epidemiology.
[5] K. Gedrich,et al. Determinants and Correlates of Serum Undercarboxylated Osteocalcin , 2008, Annals of Nutrition and Metabolism.
[6] M. Shiraki,et al. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women , 2008, Journal of Bone and Mineral Metabolism.
[7] N. Maalouf,et al. The Role of Receptor Activator of Nuclear Factor-κB (RANK)/RANK Ligand/Osteoprotegerin: Clinical Implications , 2007 .
[8] H. Takayanagi. Novel signaling pathways and therapeutic targets in osteoclasts. , 2007, Advances in experimental medicine and biology.
[9] O. Johnell,et al. Latitude, socioeconomic prosperity, mobile phones and hip fracture risk , 2007, Osteoporosis International.
[10] U. Gophna,et al. Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.
[11] S. Lanham-New,et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.
[12] K. Horie-Inoue,et al. Steroid and Xenobiotic Receptor SXR Mediates Vitamin K2-activated Transcription of Extracellular Matrix-related Genes and Collagen Accumulation in Osteoblastic Cells*♦ , 2006, Journal of Biological Chemistry.
[13] Yusuke Ohsaki,et al. Vitamin K Suppresses Lipopolysaccharide-Induced Inflammation in the Rat , 2006, Bioscience, biotechnology, and biochemistry.
[14] M. Dougados,et al. Bone loss in patients with inflammatory bowel disease: A prospective study , 1995, Osteoporosis International.
[15] E. Vasiliauskas,et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density , 2004, Gut.
[16] H. Bischoff-Ferrari,et al. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. , 2004, The American journal of medicine.
[17] M. Shearer,et al. Beyond Deficiency: , 2004, European journal of nutrition.
[18] C. Cooper,et al. Inflammatory bowel disease and the risk of fracture. , 2003, Gastroenterology.
[19] C. Mathieu,et al. Analogs of 1α,25‐dihydroxyvitamin D3 as pluripotent immunomodulators , 2003 .
[20] J. Penninger,et al. RANK-L and RANK: T cells, bone loss, and mammalian evolution. , 2002, Annual review of immunology.
[21] H. DeLuca,et al. Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] M. Takemitsu,et al. Effect of vitamin K2 on lumbar vertebral bone: histomorphometric analyses in experimental osteoporotic rats , 2001, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[23] A. Zittermann. Effects of vitamin K on calcium and bone metabolism , 2001, Current opinion in clinical nutrition and metabolic care.
[24] P. Meunier,et al. Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease? , 2001, The Lancet.
[25] T. Hotokebuchi,et al. Tumor necrosis factor-α cooperates with receptor activator of nuclear factor κB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture , 2001 .
[26] L. Schurgers,et al. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? , 2001, Gut.
[27] H Miura,et al. Effect of Vitamin K2 on Three‐Dimensional Trabecular Microarchitecture in Ovariectomized Rats , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] K. Berkner. The vitamin K-dependent carboxylase. , 2005, Annual review of nutrition.
[29] Josef M. Penninger,et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand , 1999, Nature.
[30] B. Furie,et al. Vitamin K-Dependent Biosynthesis of γ-Carboxyglutamic Acid , 1999 .
[31] Z. Tulassay,et al. Altered Bone Metabolism in Inflammatory Bowel Disease , 1998, American Journal of Gastroenterology.
[32] I. Forgacs,et al. Reduced bone density in patients with inflammatory bowel disease. , 1997, Gut.
[33] M. Yamaguchi,et al. Effect of vitamin K , 1996 .
[34] B. Henderson,et al. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. , 1995, Cytokine.
[35] M. Dougados,et al. Metabolic bone assessment in patients with inflammatory bowel disease. , 1995, Gastroenterology.
[36] M. Shiraki,et al. Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. , 1993, Biochemical pharmacology.
[37] D. Podolsky,et al. Inflammatory bowel disease (1) , 1991, The New England journal of medicine.
[38] D. Present,et al. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis , 1990, The Lancet.
[39] J. Lennard-jones,et al. Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.
[40] J. Compston,et al. Osteoporosis in patients with inflammatory bowel disease. , 1987, Gut.
[41] T. Louie,et al. Production of menaquinones by intestinal anaerobes. , 1984, The Journal of infectious diseases.
[42] F Kern,et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.